Accessibility Menu
 
Lifeline Biotechnologies logo

Lifeline Biotechnologies

(OTC) LLBO

Current Price$0.00
Market Cap$3.48M
Since IPO (1998)-100%
5 Year-56%
1 Year+167%
1 Month+33%

Lifeline Biotechnologies Financials at a Glance

Market Cap

$3.48M

Revenue (TTM)

$0.00

Net Income (TTM)

$58.30K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-117.96 (Low)

Price

$0.00

Volume

155,284

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

LLBO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lifeline Biotechnologies

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

1

CEO

James D. Holmes, MBA

Website

www.lbti.com

Headquarters

Reno, NV 89502, US

LLBO Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

0%

Return on Assets

0%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.48M

Shares Outstanding

4.35B

Volume

155.28K

Avg. Volume

1.10M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$58.30K

EBITDA

$58.30K

Operating Cash Flow

$139.82K

Capital Expenditure

$0.00

Free Cash Flow

$139.82K

Cash & ST Invst.

$415.00

Total Debt

$327.12K

Lifeline Biotechnologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$3.48M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$1.20K

+0.0%

EBITDA

$1.20K

+0.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RHEPRegional Health Properties, Inc.
$1.33+2.65%
RQHTFReliq Health Technologies Inc.
$0.01+0.00%
AXIMAXIM Biotechnologies, Inc.
$0.01-1.88%
NUMDNu-Med Plus, Inc.
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$13.85+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.26+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.84+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.50-0.01%

Questions About LLBO

What is the current price of Lifeline Biotechnologies?

Lifeline Biotechnologies is trading at $0.00 per share.

What is the 52-week range for Lifeline Biotechnologies?

Over the past 52 weeks, Lifeline Biotechnologies has traded between $0.00 and $0.00.

How much debt does Lifeline Biotechnologies have?

As of the most recent reporting period, Lifeline Biotechnologies reported total debt of N/A.

How much cash does Lifeline Biotechnologies have on hand?

Lifeline Biotechnologies reported N/A in cash and cash equivalents in its most recent financial results.

What is Lifeline Biotechnologies’s dividend yield?

Lifeline Biotechnologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services